ImmuGene will create a collaborative gene therapy network, taking advantage of UZH associated Good Laboratory Practice (GLP), Good Manufacturing  practice (GMP) at the Institute of Regenerative Medicine (IREM and Wyss Zurich), and Good Clinical Practice at the Clinical Trials Centre (CTC) facilities, as well as the Functional Genomics Centre Zurich (FGCZ).